Search by Drug Name or NDC
NDC 71399-4453-05 AsperFlex MAX 240; 60 mg/1; mg/1 Details
AsperFlex MAX 240; 60 mg/1; mg/1
AsperFlex MAX is a TOPICAL PATCH in the HUMAN OTC DRUG category. It is labeled and distributed by Akron Pharma Inc.. The primary component is LIDOCAINE; MENTHOL.
Product Information
| NDC | 71399-4453 |
|---|---|
| Product ID | 71399-4453_32c3fc0a-7237-41d0-ada7-1d4860a27d14 |
| Associated GPIs | 90859902885930 |
| GCN Sequence Number | 068770 |
| GCN Sequence Number Description | lidocaine/menthol ADH. PATCH 4 %-1 % TOPICAL |
| HIC3 | Q5H |
| HIC3 Description | TOPICAL LOCAL ANESTHETICS |
| GCN | 31613 |
| HICL Sequence Number | 007837 |
| HICL Sequence Number Description | LIDOCAINE/MENTHOL |
| Brand/Generic | Generic |
| Proprietary Name | AsperFlex MAX |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lidocaine 4% with Menthol 1% |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | PATCH |
| Route | TOPICAL |
| Active Ingredient Strength | 240; 60 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | LIDOCAINE; MENTHOL |
| Labeler Name | Akron Pharma Inc. |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part348 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71399-4453-05 (71399445305)
| NDC Package Code | 71399-4453-5 |
|---|---|
| Billing NDC | 71399445305 |
| Package | 5 PATCH in 1 CARTON (71399-4453-5) / 1 PATCH in 1 PATCH |
| Marketing Start Date | 2021-11-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |